baber/WOPTO huggingface dataset:
Patent AU-2005330619-B2 (AU)
Title: A system and method for protecting the privacy and security of stored biometric data
Inventor: MICHAEL PEIRCE
IPC: G06F1/00
Filed: 2005-04-22
Granted: 2011-08-11
Abstract: A data storage system that protects privacy and ensures security is described. The system includes a plurality of nodes in a networked architecture, the nodes being adapted to securely communicate and co-operate with one another to allow storage and retrieval of data. A single piece of biometric data is associated only with a blinded identifier and securely divided across one or more nodes, adapted for data storage. The data itself and the link to the original individual, from whom the biometric was acquired, cannot be obtained without the co-operation of two or more nodes.
Patent AU-2006308695-B2 (AU)
Title: Blowing agents for forming foam comprising unsaturated fluorocarbons
Inventor: SWEARINGEN EKATERINA N
IPC: C08J9/14
Filed: 2006-11-01
Granted: 2012-09-20
Abstract: Disclosed herein are blowing agents comprising fluorocarbons and/or hydrofluorocarbons useful in foamable compositions. Also disclosed are methods for forming a foam comprising the aforementioned blowing agents.
Patent AU-2007212501-B2 (AU)
Title: Polymeric, degradable drug-eluting stents and coatings
Inventor: MARTIN DAVID P
IPC: A61L31/04
Filed: 2007-02-06
Granted: 2011-03-31
Abstract: Toughened compositions of PLA and PLA copolymers are disclosed, which also have low tensile modulus values and greater elongation to break. These toughened compositions are prepared by blending PLA and PLA copolymers with poly-4-hydroxybutyrate, and copolymers thereof. Blending of poly-4-hydroxybutyrate with PLA and its copolymers has been found to impart advantageous properties to the resulting blend. These compositions, and objects formed from these compositions, have improved toughness and lower stiffness than polylactic acid polymers or copolymers alone.
Patent AU-2007242061-B2 (AU)
Title: Pestivirus species
Inventor: FINLAISON DEBORAH SUSAN
IPC: C12N15/40
Filed: 2007-04-20
Granted: 2012-11-29
Abstract: The application relates to a pestivirus, designated PMC virus, that is associated with porcine myocarditis syndrome, and the gene and protein sequences derived therefrom. The application further relates to detection methods, vaccine therapeutics, and diagnostic methods using the PMC virus or gene/protein sequences derived therefrom.
Patent AU-2007243769-B2 (AU)
Title: Hot processing of polyurethane carpet backing systems using dual delayed action catalyst
Inventor: JENKINES RANDALL C
IPC: C08G18/66
Filed: 2007-03-19
Granted: 2012-04-05
Abstract: A process for preparing polyurethane carpet backings uses a filled polyurethane-forming composition that contains a mixture of certain metal acetylacetonate and sulfur- containing organotin catalysts. The mixture of catalysts is particularly beneficial in instances where the composition is processed at temperatures of above 30 to about 500C, as long pot life is provided together with a rapid thermally-induced cure.
Patent AU-2007253903-B2 (AU)
Title: Use of non-agrobacterium bacterial species for plant transformation
Inventor: WILLIAMS EDWARD
IPC: C12N15/82
Filed: 2007-05-16
Granted: 2012-07-19
Abstract: The invention relates to methods for Rhizobia-mediated genetic transformation of plant cells, including soybean, canola, corn, and cotton cells. These include both VirD2 -dependent and VirD2 -independent methods. Bacterial species utilized include strains of sp., sp., and sp. Vectors for use in such transformation are also disclosed.
Patent AU-2007292481-B2 (AU)
Title: Apparatus suitable for performing mucosal resection
Inventor: KARPIEL JOHN A
IPC: A61B1/018
Filed: 2007-09-04
Granted: 2013-08-29
Abstract: The present invention provides apparatus and methods for performing endoscopic mucosal resection and endoscopic submucosal dissection of tissue. In a first embodiment, a hood member having a hood portion and a lever portion is provided. The hood portion is adapted to be disposed over a distal region of an endoscope. A portion of the lever portion is configured to be inserted beneath a section of mucosal tissue having a lesion, and the lever portion is configured to be rotated or otherwise maneuvered to lift the mucosal tissue in an upward direction, thereby facilitating removal of the tissue comprising the lesion. Optionally, a surgeon may advance a needle knife through the endoscope and lever portion to further incise submucosal tissue while the lever portion is disposed beneath the lesion. If desired, a flushing fluid may be provided to a target site during the procedure.
Patent AU-2007322017-B2 (AU)
Title: Plant growth and imaging devices and related methods and computer program products
Inventor: CLARK ROBERT
IPC: A01C14/00
Filed: 2007-11-19
Granted: 2013-11-07
Abstract: A plant growth array device includes an aerial growth chamber configured to receive aerial shoot portions of a plurality of plants and a root growth chamber configured to receive root portions of the plurality of plants. A dividing member is between the aerial growth chamber and the root chamber and has a plurality of apertures for receiving the plurality of plants therein. The plurality of apertures are configured so that the root portions grow substantially in a common orientation.
Patent AU-2008201132-B2 (AU)
Title: Method of identifying compartmentalization of a reservoir
Inventor: DAVIS ROBERT CHARLES
IPC: G01V9/00
Filed: 2008-03-11
Granted: 2013-04-04
Abstract: Abstract A method of identifying compartmentalization of a reservoir is described. The method 5 comprises the steps of a) obtaining a plurality of fluid samples of a reservoir, the plurality of fluid samples taken from a plurality of locations in the reservoir; b) analyzing the plurality of fluid samples to obtain a plurality of compositional data points, each compositional data point providing a representation of the concentration of carbon dioxide present in a given fluid sample; c) analyzing the plurality of fluid samples to obtain a plurality of isotopic data points, .0 each isotopic data point provides a representation of the stable isotope ratio of carbon dioxide or oxygen present in a given fluid sample; d) plotting the plurality of compositional data points against the plurality of isotopic data points for each of the plurality of locations; and, e) analyzing the proximity of the plotted plurality of compositional and isotopic data points as an indication of the degree of compartmentalization of the reservoir. Fluid Sampling Gas Analysis Data Plotting j 106 Assess Level of Compartmentalization 108 Figure 1
Patent AU-2008223302-B2 (AU)
Title: Treated refractory material and methods of making
Inventor: MESCHTER PETER JOEL
IPC: C04B41/50
Filed: 2008-02-06
Granted: 2012-02-02
Abstract: A treated refractory material includes a sintered porous refractory material having one or more protective materials disposed within pores of the refractory material, wherein the protective material is selected from the group consisting of aluminum oxide, chromium oxide, silica, rare earth oxides, rare earth zirconates, titanium oxide, mullite, zirconium oxide, zirconium silicate, yttrium oxide, magnesium oxide, iron oxide, and blends thereof. Methods of preparing the treated refractory material are also provided. The treated refractory material provides protection from the penetration of slag and extends the service life of the refractory.
Patent AU-2008244074-B2 (AU)
Title: Antibodies against RAMP3
Inventor: RICHARDS GARETH OWEN
IPC: A61P9/00
Filed: 2008-04-23
Granted: 2014-06-26
Abstract: The present invention provides an isolated antibody capable of binding a receptor activity modifying protein (RAMP) of CRLR receptor which antibody is of IgG, IgA or IgM isotype.
Patent AU-2008263629-B2 (AU)
Title: Holographic security device
Inventor: HOLMES BRIAN WILLIAM
IPC: B42D15/10
Filed: 2008-06-12
Granted: 2013-03-14
Abstract: A holographic security device comprising at least first and second diffractive image generating structures (11,13) recorded in respective sets of substantially non- overlapping regions of a record medium, the regions of one set being interleaved with regions of the other set, whereby both interleaved regions are substantially non- visible to the unaided eye. The holographic security device generates two or more holographic images viewed from separate and/or overlapping viewing directions around the device and seen by tilting the device, and each particular holographic image in a viewing direction is generated by the diffractive image generating structure (11,13) associated with one set of interleaved lines. The first diffractive image generating structure has been formed to have a diffuse diffractive replay and the second diffractive image generating structure has been formed to have a non- diffuse or specular diffractive replay.
Patent AU-2008299576-B2 (AU)
Title: An interface element for a computer interface
Inventor: APTED TRENT
IPC: G06T3/40
Filed: 2008-09-11
Granted: 2014-04-03
Abstract: The present invention provides method of manipulating a displayed object capable of interacting with an interface element of a computing interface. The computing interface has a display module for displaying the displayed object in a display area, and which causes the displayed object to interact with the interface element and manipulating the displayed object according to the nature of the input received. The manipulation includes varying the size of the displayed object when the received input results in movement of the displayed object, into, out-of, or through a region of the display area designated as belonging to the interface element.
Patent AU-2008299883-B2 (AU)
Title: Processing of gesture-based user interactions
Inventor: VIETA MATTHEW
IPC: G06F17/00
Filed: 2008-09-15
Granted: 2012-03-15
Abstract: Systems and methods for processing gesture-based user interactions with an interactive display.
Patent AU-2008303230-B2 (AU)
Title: Composition and method of stabilized sensitive ingredient
Inventor: CIMILUCA PAUL ALFRED
IPC: A61K9/20
Filed: 2008-09-24
Granted: 2014-07-03
Abstract: The present invention comprises a method of achieving ingredient stabilization in a composition comprising the steps of: combining a pregelatinized starch with at least one sensitive ingredient; adsorbing said sensitive ingredient onto the pregelatinized starch; and wherein said sensitive ingredient is evenly distributed throughout said pregelatinized starch.
Patent AU-2008310481-B2 (AU)
Title: Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
Inventor: SAKAMOTO KAZUKI
IPC: A61P29/00
Filed: 2008-10-10
Granted: 2013-05-23
Abstract: Disclosed is a therapeutic agent for inflammatory bowel disease. Specifically disclosed is a therapeutic agent for inflammatory bowel disease, which comprises a uracil derivative represented by the general formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient.
Patent AU-2008316499-B2 (AU)
Title: Polymer material and method for the production thereof
Inventor: HESS CHRISTOPH
IPC: C08L63/00
Filed: 2008-10-22
Granted: 2012-03-22
Abstract: A method for the production of a polymer material is shown and described, which is characterized by: (a) producing a mixture containing at least 1 to 75 wt.-% starch and/or starch derivative, 10 to 85 wt.-% polyester, and 0.01 to 7 wt.-% of a polymer containing an epoxy group; (b) homogenizing the mixture while supplying thermal and/or mechanical energy; (c) setting the water content of the mixture, so that the end product has a water content of less than approximately 12 wt.-%, in relation to the total composition of the mixture. The polymer material produced with the method according to the invention is characterized by outstanding mechanical properties.
Patent AU-2008320195-B2 (AU)
Title: Humidity control apparatus
Inventor: NOBUKI MATSUI
IPC: F24F3/147
Filed: 2008-10-30
Granted: 2011-12-22
Abstract: A humidity control device (10) has a casing (11), air discharge and supply fans (25, 26) and dampers (41-48, 83, 84) for performing ventilation between outdoor air and indoor air via air paths (31-34, 37, 38, 81, 82) of the casing (11), and a refrigerant circuit (50) for controlling the humidity of air flowing in the air paths. The humidity control device (10) further has a controller (60) for monitoring abnormality in the device and determining the type of a detected abnormality. When a detected abnormality is an abnormality relating to the refrigerant circuit (50) and not an abnormality relating to the air discharge and supply fans (25, 26) and the dampers (41-48, 83, 84), the controller (60) stops a refrigeration cycle of the refrigerant circuit (50) to stop humidity control operation and enables ventilation operation.
Patent AU-2008335240-B2 (AU)
Title: Dermatome blade assembly
Inventor: BARKER DOUGLAS C
IPC: A61B17/32
Filed: 2008-12-09
Granted: 2013-08-15
Abstract: A dermatome has a main body with a first profile and at least one blade assembly with a blade, a size, an orientation corresponding to the main body, and a second profile. The second profile has characteristics corresponding to the first profile to properly orient and locate the at least one blade for proper mounting of the blade to the main body. The profiles are shaped to provide clearance for the second profile to reciprocate relative to the first profile.
Patent AU-2008357657-B2 (AU)
Title: Active delivery oral care implement
Inventor: GATZEMEYER JOHN J
IPC: A46B11/00
Filed: 2008-06-13
Granted: 2012-02-09
Abstract: An oral care implement includes a head (12), a handle (10), a neck portion (11) connecting the head and the handle, and a reservoir (15) located in the neck portion which contains at least one active agent. The implement has an activator (22) for activating a delivery device which delivers the active agent to one or more outlets (50). A wide variety of types of active agents may be administered at appropriate and accurate doses for therapeutic, hygienic, and/ or other benefit.
Patent AU-2009201588-B2 (AU)
Title: Growth factor modified protein matrices for tissue engineering
Inventor: LUTOLF MATTHIAS
IPC: C12N5/071
Filed: 2009-04-21
Granted: 2011-02-24
Abstract: Proteins are incorporated into protein or polysaccharide matrices for use in tissue repair, regeneration and/or remodeling and/or drug delivery. The proteins can be incorporated so that they are released by degradation of the matrix, by enzymatic action and/or diffusion. As demonstrated by the examples, one method is to bind heparin to the matrix by either covalent or non-covalent methods, to form a heparin-matrix. The heparin then non-covalently binds heparin-binding growth factors to the protein matrix. Alternatively, a fusion protein can be constructed which contains a crosslinking region such as a factor XIIIa substrate and the native protein sequence. Incorporation of degradable linkages between the matrix and the bioactive factors can be particularly useful when long-term drug delivery is desired, for example in the case of nerve regeneration, where it is desirable to vary the rate of drug release spatially as a function of regeneration, e.g. rapidly near the living tissue interface and more slowly farther into the injury zone. Additional benefits include the lower total drug dose within the delivery system, and spatial regulation of release which permits a greater percentage of the drug to be released at the time of greatest cellular activity.
Patent AU-2009205645-B2 (AU)
Title: A practical model for high speed file delivery services supporting guaranteed delivery times and differentiated service levels
Inventor: XU YING
IPC: H04L47/52
Filed: 2009-01-16
Granted: 2014-05-01
Abstract: A practical economic and technical model for building commercial-grade electronic file delivery services that provide the same scale, predictability, and differentiated service levels as physical courier services traditionally used to move electronic data on physical media. Systems and methods for providing such services using a charge-back scheme based on congestion pricing are described.
Patent AU-2009225332-B2 (AU)
Title: Hemostatic implant
Inventor: BENNETT STEVEN
IPC: A61L33/06
Filed: 2009-10-13
Granted: 2014-07-03
Abstract: HEMOSTA TIC IMPLANT Abstract The present disclosure relates to hemostatic implants including a porous substrate s having a first hydrogel precursor and a second hydrogel precursor applied thereto in a manner such that the first hydrogel precursor and second hydrogel precursor do not react with each other until the implant is placed at the site of implantation and exposed to the physiological fluids of a patient.
Patent AU-2009248679-B2 (AU)
Title: Cellular ceramic plates with asymmetrical cell structure and manufacturing method thereof
Inventor: STRAUVEN HANS
IPC: C03B19/08
Filed: 2009-05-25
Granted: 2013-11-28
Abstract: A method for the continuous production of a cellular ceramic or glass plate having asymmetric cells comprising thermally treating ceramic particles and a blowing agent in a foaming furnace (3) while conveying said ceramic particles and said blowing agent at a first speed thereby forming a cellular ceramic plate, and annealing said cellular ceramic plate in an annealing lehr (4) by cooling it down while conveying it at a second speed, larger than said first speed, thereby stretching and cooling said cellular ceramic or glass plate.
Patent AU-2009253435-B2 (AU)
Title: Apparatus for the directed introduction of primary combustion air into the gas space of a coke-oven battery
Inventor: KIM RONALD
IPC: C10B15/02
Filed: 2009-04-28
Granted: 2015-04-23
Abstract: The invention relates to an apparatus for the directed channelling of primary air into a coke-chamber oven, wherein this primary air is channelled through the coke-chamber ceiling into the gas space of a coke-oven battery and, upon entering into the gas space of the coke chamber, is deflected laterally, the primary air therefore being better distributed. The invention also relates to a method of laterally deflecting the primary air once it has entered into the coke-oven chamber, this resulting in better distribution of the primary air in the coke-oven chamber.
Patent AU-2009286332-B2 (AU)
Title: Thin, smooth nitrile rubber gloves
Inventor: LIPINSKI TIMOTHY M
IPC: B32B13/12
Filed: 2009-08-27
Granted: 2014-12-11
Abstract: A nitrile-rubber medical exam glove composed of a glove body which is a flexible layer of nitrile-butadiene rubber. The glove body has a chlorinated first surface forming a donning side of the glove body and an un-chlorinated second surface forming a grip side of the glove body. The elastomeric glove also includes a substantially uniform distribution of a release agent distributed over the un-chlorinated second surface of the glove body. The elastomeric glove has: (a) an average thickness of between about 0.03 to 0.12 mm in a palm region of the glove body as measured in accordance with ASTM D3767, procedure A; (b) an un-chlorinated second surface of the glove body characterized by a Surface Root Mean Square Roughness of from about 3.00 Î¼m to about 6.55 Î¼m; and (c) a failure rate of less than about 1 percent when the elastomeric glove is subjected to pinhole leak testing generally in accordance with ASTM D5151-06.
Patent AU-2009303331-B2 (AU)
Title: Phase-separated biocompatible polymer compositions for medical uses
Inventor: BRANDOM DON K
IPC: A61K9/14
Filed: 2009-10-11
Granted: 2014-07-17
Abstract: A variety of phase-separated biocompatible polymer compositions are described. In preferred embodiments the polymers are bioresorbable and/or biodegradable, and have desirable mechanical properties, such as fracture and/or fatigue toughness, that have previously not been a primary design criteria for such polymers. The polymer compositions are useful in a variety of medical applications, such as in the fabrication of medical devices.
Patent AU-2010202503-B2 (AU)
Title: DPI formulation containing sulfoalkyl ether cyclodextrin
Inventor: PIPKIN JAMES D
IPC: A61K9/00
Filed: 2010-06-16
Granted: 2012-12-13
Abstract: An inhalable dry powder formulation containing SAE-CD and an active agent is provided. The formulation is adapted for administration by DPI. The SAE CD serves as a carrier rather than as an absorption enhancer. The average particle size of the SAE-CD is large enough to preclude (for the most part) pulmonary deposition thereof. Following release from the DPI device, the SAE CD-containing particles dissociate from the active agent-containing particles in the buccal cavity or throat, after which the active agent-containing particles continue deeper into the respiratory tract. The physicochemical and morphological properties of the SAE-CD are easily modified to permit optimization of active agent and carrier interactions. Drugs having a positive, neutral or negative -electrostatic charge can be delivered by DPI when SAE-CD is used as a carrier.
Patent AU-2010213871-B2 (AU)
Title: Use of aluminum phosphate, polyphosphate and metaphosphate particles in paper coating applications
Inventor: GALEMBECK FERNANDO
IPC: D21H19/38
Filed: 2010-02-10
Granted: 2014-10-02
Abstract: Provided herein are coating compositions for paper comprising aluminum phosphate, aluminum metaphosphate, aluminum orthophosphate and/or aluminum polyphosphate pigments. Methods of making and using the compositions are described.
Patent AU-2010221418-B2 (AU)
Title: Diagnostic devices and methods of use
Inventor: VALLA JON E
IPC: B01D25/00
Filed: 2010-03-02
Granted: 2015-06-04
Abstract: The present invention relates to methods of diagnosing samples as well as various microfluidic, microcentrifuge and microfilter devices. In one embodiment, the present invention provides a method of diagnosing neurodegenerative diseases using mitochondrial and/or platelet samples. In another embodiment, the present invention provides a microfluidic device that selectively captures and analyzes a desired amount of target biological particle.
Patent AU-2010229147-B2 (AU)
Title: Amino ester derivatives, salts thereof and methods of use
Inventor: XI NING
IPC: C07D401/12
Filed: 2010-03-15
Granted: 2012-07-05
Abstract: The present invention provides amino ester compounds, salts, and pharmaceutical formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
Patent AU-2010245926-B2 (AU)
Title: Communication cable with improved electrical characteristics
Inventor: NORDIN RONALD A
IPC: H01B11/10
Filed: 2010-05-05
Granted: 2014-10-16
Abstract: A communication cable is provided with a plurality of twisted pairs of conductors and a matrix tape having conductive segments separated by gaps. The dimensions of the conductive segments are selected to reduce the undesirable coupling of signals between adjacent cables. An insulating layer may be provided between the twisted pairs of conductors and the matrix tape. In some embodiments, the insulating layer is an embossed or perforated film. The use of an embossed or perforated film decreases the dielectric constant of the insulating layer.
Patent AU-2010255762-B2 (AU)
Title: Medicated module with integral flow distribution system
Inventor: DAVIES JAMES ALEXANDER
IPC: A61M5/20
Filed: 2010-06-01
Granted: 2015-01-22
Abstract: A medicated module (4) for an injection system to co-deliver at least two medicaments (1, 2) is disclosed where a primary delivery device (7) containing a primary medicament (1) accepts a medicated module (4) containing a single dose of a secondary medicament (2) contained within a capsule (31) having an integral flow distributor/distribution system (23) and where both medicaments (1, 2) are delivered through a single hollow needle (3).